Canada markets closed

Dechra Pharmaceuticals PLC (DPH.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
4,200.00-90.00 (-2.10%)
At close: 04:36PM GMT
Currency in GBp

Valuation Measures4

Market Cap (intraday) 5.41B
Enterprise Value 5.61B
Trailing P/E 97.90
Forward P/E 43.86
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)8.94
Price/Book (mrq)8.55
Enterprise Value/Revenue 9.23
Enterprise Value/EBITDA 35.30

Trading Information

Stock Price History

Beta (5Y Monthly) 0.47
52-Week Change 315.26%
S&P500 52-Week Change 322.74%
52 Week High 35,525.00
52 Week Low 33,236.00
50-Day Moving Average 34,984.02
200-Day Moving Average 34,637.21

Share Statistics

Avg Vol (3 month) 3368.78k
Avg Vol (10 day) 3329.85k
Shares Outstanding 5108.36M
Implied Shares Outstanding 6N/A
Float 8107.73M
% Held by Insiders 11.43%
% Held by Institutions 170.19%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.41
Forward Annual Dividend Yield 40.96%
Trailing Annual Dividend Rate 30.41
Trailing Annual Dividend Yield 30.01%
5 Year Average Dividend Yield 40.99
Payout Ratio 468.80%
Dividend Date 3N/A
Ex-Dividend Date 4Oct. 28, 2021
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Jun. 30, 2021
Most Recent Quarter (mrq)Jun. 30, 2021


Profit Margin 9.13%
Operating Margin (ttm)14.31%

Management Effectiveness

Return on Assets (ttm)4.44%
Return on Equity (ttm)8.74%

Income Statement

Revenue (ttm)608M
Revenue Per Share (ttm)5.62
Quarterly Revenue Growth (yoy)15.60%
Gross Profit (ttm)345.9M
Net Income Avi to Common (ttm)55.5M
Diluted EPS (ttm)51.00
Quarterly Earnings Growth (yoy)55.60%

Balance Sheet

Total Cash (mrq)118.4M
Total Cash Per Share (mrq)1.09
Total Debt (mrq)318.6M
Total Debt/Equity (mrq)50.34
Current Ratio (mrq)2.52
Book Value Per Share (mrq)5.85

Cash Flow Statement

Operating Cash Flow (ttm)89.1M
Levered Free Cash Flow (ttm)-23.82M